News / Events :: Avalo Therapeutics, Inc. (AVTX)

News / Events

Recent News

Feb 2, 2023 • 9:54 PM EST

Avalo Therapeutics, Inc. Announces Pricing of $15 Million Public Offering of Common Stock and Warrants

Feb 2, 2023 • 4:01 PM EST

Avalo Therapeutics, Inc. Announces Proposed Public Offering of Common Stock and Warrants

Jan 17, 2023 • 7:00 AM EST

Avalo Announces it Has Completed Targeted Enrollment of 80 Patients in Phase 2 PEAK Trial of AVTX-002 in Non-Eosinophilic Asthma

Recent Events

September 12 – September 14, 2022

H.C. Wainwright Global Investment Conference